What Are the Challenges in Targeting the Transcription Initiation Complex for Cancer Therapy?
Despite its potential, targeting the transcription initiation complex poses several challenges. One major issue is the selectivity of drugs, as these components are also essential for normal cell function. Another challenge is the complexity of the interactions within the complex, making it difficult to identify specific targets. Moreover, cancer cells may develop resistance to therapies aimed at the transcription initiation complex.
